• Home
  • Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial.

Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial.

Author List
Lopes Cardozo JMN, Drukker CA, Rutgers EJT, Schmidt MK, Glas AM, Witteveen A, Cardoso F, Piccart M, Esserman LJ, Poncet C, van 't Veer LJ
Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/259898954
Publication Year
2022
PubMed ID
35061525
Publication Title
Lopes Cardozo JMN, Drukker CA, Rutgers EJT, Schmidt MK, Glas AM, Witteveen A, Cardoso F, Piccart M, Esserman LJ, Poncet C, van 't Veer LJ. Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial. J Clin Oncol. 2022 04 20; 40(12):1335-1345.